Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

STAG2 loss rewires oncogenic and developmental programs to promote metastasis in Ewing sarcoma
Biniam Adane, Gabriela Alexe, Bo Kyung A. Seong, et al.
Cancer Cell (2021) Vol. 39, Iss. 6, pp. 827-844.e10
Open Access | Times Cited: 89

Showing 1-25 of 89 citing articles:

TRIM8 modulates the EWS/FLI oncoprotein to promote survival in Ewing sarcoma
Bo Kyung A. Seong, Neekesh V. Dharia, Shan Lin, et al.
Cancer Cell (2021) Vol. 39, Iss. 9, pp. 1262-1278.e7
Open Access | Times Cited: 76
Mechanisms, Diagnosis and Treatment of Bone Metastases
Jozef Ban, Valerie Fock, Dave N.T. Aryee, et al.
Cells (2021) Vol. 10, Iss. 11, pp. 2944-2944
Open Access | Times Cited: 64
Systematic multi-omics cell line profiling uncovers principles of Ewing sarcoma fusion oncogene-mediated gene regulation
Martin F. Orth, Didier Surdez, Tobias Faehling, et al.
Cell Reports (2022) Vol. 41, Iss. 10, pp. 111761-111761
Open Access | Times Cited: 42
The ETS transcription factor ETV6 constrains the transcriptional activity of EWS–FLI to promote Ewing sarcoma
Diana Lu, Jana M. Ellegast, Kenneth N. Ross, et al.
Nature Cell Biology (2023)
Open Access | Times Cited: 26
ETV6 dependency in Ewing sarcoma by antagonism of EWS-FLI1-mediated enhancer activation
Yuan Gao, Xue‐Yan He, Xiaoli Wu, et al.
Nature Cell Biology (2023)
Open Access | Times Cited: 23
Integrative analysis of Ewing’s sarcoma reveals that the MIF-CD74 axis is a target for immunotherapy
Fangzhou He, Jiuhui Xu, Fanwei Zeng, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 1
Compromised epigenetic robustness in cancer: fueling evolution, exposing weakness
Thomas Stuart Wilson, Paola Scaffidi
Trends in cancer (2025)
Open Access | Times Cited: 1
EWS/FLI mediated reprogramming of 3D chromatin promotes an altered transcriptional state in Ewing sarcoma
Iftekhar A. Showpnil, Julia Selich‐Anderson, Cenny Taslim, et al.
Nucleic Acids Research (2022) Vol. 50, Iss. 17, pp. 9814-9837
Open Access | Times Cited: 38
Full circle: a brief history of cohesin and the regulation of gene expression
Julia A. Horsfield
FEBS Journal (2022) Vol. 290, Iss. 7, pp. 1670-1687
Open Access | Times Cited: 33
An international working group consensus report for the prioritization of molecular biomarkers for Ewing sarcoma
David S. Shulman, Sarah Burkhead Whittle, Didier Surdez, et al.
npj Precision Oncology (2022) Vol. 6, Iss. 1
Open Access | Times Cited: 31
VRK1 Is a Synthetic–Lethal Target in VRK2-Deficient Glioblastoma
Julie A. Shields, Samuel R. Meier, Madhavi Bandi, et al.
Cancer Research (2022) Vol. 82, Iss. 21, pp. 4044-4057
Open Access | Times Cited: 30
Open-Label, Multicenter, Phase I/II, First-in-Human Trial of TK216: A First-Generation EWS::FLI1 Fusion Protein Antagonist in Ewing Sarcoma
Paul A. Meyers, Noah Federman, Najat C. Daw, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 31, pp. 3725-3734
Closed Access | Times Cited: 7
Prion-like domain mediated phase separation of ARID1A promotes oncogenic potential of Ewing’s sarcoma
Yong Ryoul Kim, Jaegeon Joo, Hee Jung Lee, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 6
Hypoxia-activated neuropeptide Y/Y5 receptor/RhoA pathway triggers chromosomal instability and bone metastasis in Ewing sarcoma
Congyi Lu, Akanksha Mahajan, Sung-Hyeok Hong, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 23
ETS transcription factors: Multifaceted players from cancer progression to tumor immunity
Yufei Wang, Zhao Huang, Mengyu Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1878, Iss. 3, pp. 188872-188872
Closed Access | Times Cited: 15
Biological sample collection to advance research and treatment: a Fight Osteosarcoma Through European Research (FOSTER) and Euro Ewing Consortium (EEC) statement.
Darrell Green, Roelof van Ewijk, Elisa Tirtei, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 16, pp. 3395-3406
Open Access | Times Cited: 5
Biologic and Clinical Analysis of Childhood Gamma Delta T-ALL Identifies LMO2/STAG2 Rearrangements as Extremely High Risk
Shunsuke Kimura, Chun Shik Park, Lindsey E. Montefiori, et al.
Cancer Discovery (2024) Vol. 14, Iss. 10, pp. 1838-1859
Closed Access | Times Cited: 5
STAG2 mutations reshape the cohesin-structured spatial chromatin architecture to drive gene regulation in acute myeloid leukemia
Alexander Fischer, Benjamín Hernández-Rodríguez, Roger Mulet‐Lazaro, et al.
Cell Reports (2024) Vol. 43, Iss. 8, pp. 114498-114498
Open Access | Times Cited: 5
The importance of fusion protein activity in Ewing sarcoma and the cell intrinsic and extrinsic factors that regulate it: A review
April A. Apfelbaum, Emma D. Wrenn, Elizabeth R. Lawlor
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 22
EWS::FLI1 and HOXD13 Control Tumor Cell Plasticity in Ewing Sarcoma
April A. Apfelbaum, Feinan Wu, Allegra G. Hawkins, et al.
Clinical Cancer Research (2022) Vol. 28, Iss. 20, pp. 4466-4478
Open Access | Times Cited: 19
EWS/FLI1 Characterization, Activation, Repression, Target Genes and Therapeutic Opportunities in Ewing Sarcoma
Muhammad Yasir, Jin‐Young Park, Wanjoo Chun
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 20, pp. 15173-15173
Open Access | Times Cited: 11
STAG2 mutations regulate 3D genome organization, chromatin loops, and Polycomb signaling in glioblastoma multiforme
Wanying Xu, Jung-Sik Kim, Tianyi Yang, et al.
Journal of Biological Chemistry (2024) Vol. 300, Iss. 6, pp. 107341-107341
Open Access | Times Cited: 4
Viral oncogene EBNALP regulates YY1 DNA binding and alters host 3D genome organization
Chong Wang, Merrin Man‐Long Leong, Weiyue Ding, et al.
EMBO Reports (2025)
Open Access
Multi‐omics profiling reveals key factors involved in Ewing sarcoma metastasis
Mariona Chicón‐Bosch, Sara Sánchez‐Serra, Marta Rosàs‐Lapeña, et al.
Molecular Oncology (2025)
Open Access
Molecular characterization informs prognosis in patients with localized Ewing sarcoma: A report from the Children's Oncology Group
Riaz Gillani, David S. Shulman, Natalie J. DelRocco, et al.
medRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Page 1 - Next Page

Scroll to top